Intravenous Immunoglobulins Market set for rapid growth forecst 2020-2025| Key Players: CSL Behring, Grifols., Kedrion Biopharma, Octapharma, Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings, Inc., and Shanghai RAAS Blood Products Co., Ltd.
Pune, India -- (SBWIRE) -- 03/13/2020 -- The global prevalence of primary immunodeficiency is rising, giving impetus to the global "intravenous immunoglobulins market". A report is published by Fortune Business Insights, titled "INTRAVENOUS IMMUNOGLOBULINS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2018-2025," offers in-depth insights into the market. As per the report, in 2017 the global market was worth US$ 9,787.6 Mn. The market is anticipated to further expand at a CAGR of 6.2% and reach US$ 15,789.1 by the end of 2025. In terms of indication, the report classifies the global market in primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), and others. Primary immunodeficiency was leading the market in 2017. The segment accounted for 28.6% of the global market in 2017. During the forecast period 2018-2025, the segment is likely to witness expansion at an impressive pace.
Highlights of the Report:
In-depth analysis of various insights, namely, Intravenous Immunoglobulins Market trends, growth drivers, opportunities, and other related challenges.
Comprehensive details of key market players, their core competencies, and Intravenous Immunoglobulins Market share.
The potency of suppliers and buyers to make better business decisions.
Lists out the market size in terms of volume.
Key Players Operating in The Intravenous Immunoglobulins Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
CSL Behring
Grifols
A.
Kedrion S.p.A
Octapharma
Bio Products Laboratory Ltd.
Biotest AG
China Biologic Products Holdings, Inc.
LFB SA
Shanghai RAAS Blood Products Co., Ltd.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intravenous-immunoglobulins-market-100593
Intravenous Immunoglobulin Application in Hospitals to Rise Persistently
Intravenous immunoglobulin is the most common route of administration of immunoglobulins, which is the chief driver of the global market. The rising demand from hospitals and specialty clinics is anticipated to encourage the adoption of intravenous immunoglobulins. Furthermore, key companies are increasingly investing in research and development of advanced intravenous immunoglobulins. Such researches are likely to enable growth in the market over the forecast period. Immunoglobulins are proven to be one of the best treatment options for various immune diseases. Owing to the high popularity of immunoglobulins, the market is foreseen to witness high demand.
North America to Continue Dominating Global Market
The North America intravenous immunoglobulins market was worth US$ 5,587.4 Mn in 2017. The region is further expected to emerge dominant over the forecast period. The increasing number of patients in the region is anticipated to drive the regional market. Moreover, in terms of dominance of route of administration, intravenous (IV) is the most dominating type in developing nations. This is likely to enable growth in market. Besides this, the advanced intravenous immunoglobulins are being rapidly adopted in developed nations. This in response is fueling the demand in market. Asia Pacific is anticipated to expand at a promising CAGR. Owing to the high prevalence of primary immunodeficiency in Asian population, the market is foreseen to witness demand for immunoglobulin.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/intravenous-immunoglobulins-market-100593
Detailed Table of Content:
Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Pipeline Analysis
Overview of Regulatory Scenario by Key Regions
Key Industry Developments
Number (Estimated) of Primary Immunodeficiency (PI) Patients by Key Countries
Overview of Reimbursement Scenario
Global Intravenous Immunoglobulins Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Indication
Primary Immunodeficiency
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Guillain-Barré Syndrome (GBS)
Immune Thrombocytopenic Purpura (ITP)
Multifocal Motor Neuropathy (MMN)
Others
Market Analysis, Insights and Forecast – By Form
Liquid
Lyophilized
Market Analysis, Insights and Forecast – By End User
Hospitals
Clinics
Homecare
Market Analysis, Insights and Forecast – By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Continued…
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593
Report Focus:
Extensive product offerings
Customer research services
Robust research methodology
Comprehensive reports
Latest technological developments
Value chain analysis
Potential Intravenous Immunoglobulins Market opportunities
Growth dynamics
Quality assurance
Post-sales support
Regular report updates
Reasons to Purchase this Report:
Comprehensive analysis of the Intravenous Immunoglobulins Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.
KEY QUESTIONS ANSWERED:
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the Intravenous Immunoglobulins Market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Related Reports:
https://www.globenewswire.com/news-release/2020/02/03/1978727/0/en/Wheelchair-Market-to-Reach-8-09-Billion-with-7-0-CAGR-by-2026-Global-Market-Size-Share-Trends-Growth-Analysis-Report.html
https://www.globenewswire.com/news-release/2020/01/17/1971971/0/en/Pet-Insurance-Market-to-Reach-11-25-Billion-by-2026-Flexibility-in-Premium-Policies-Will-Provide-Impetus-to-Market-Growth-says-Fortune-Business-Insights.html
About Fortune Business Insights™
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs